The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Prognostic Factors for Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study
Open accessAbstract
Purpose: Conflicting results on prognostic factors for advanced epithelial ovarian cancer (EOC) have been reported because of small sample size and heterogeneity of study population. The purpose of this study was to identify factors predictive of poor prognosis in a similarly treated population of women with advanced EOC. Patients and Methods: A retrospective review of demographic, pathologic, treatment, and outcome data from 1,895 patients with International Federation of Gynecology and Obstetrics stage III EOC who had undergone primary surgery followed by six cycles of intravenous platinum/paclitaxel was conducted. A proportional hazards model was used to assess the association of prognostic factors with progression-free survival (PFS) and overall survival (OS). Results: Increasing age was associated with increased risks for disease progression (HR = 1.06; 95% CI, 1.02 to 1.11 for an increase every 10 years) and death (HR = 1.12; 95% CI, 1.06 to 1.18). Mucinous or clear-cell histology was associated with a worse PFS and OS compared with serous carcinomas. Patients with performance status (PS) 1 or 2 were at an increased risk for recurrence compared with PS 0 (HR = 1.12; 95% CI, 1.01 to 1.24). Compared with patients with microscopic residual disease, patients with 0.1 to 1.0 cm and > 1.0 cm residual disease had an increased risk of recurrence (HR = 1.96; 95% CI, 1.70 to 2.26; and HR = 2.36; 95% CI, 2.04 to 2.73, respectively) and death (HR = 2.11; 95% CI, 1.78 to 2.49; P < .001; and HR = 2.47; 95% CI, 2.09 to 2.92, respectively). Conclusion: Age, PS, tumor histology, and residual tumor volume were independent predictors of prognosis in patients with stage III EOC. These data can be used to identify patients with poor prognosis and to design future tailored randomized clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J., & Thun, M. J. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.1.10 · Cited by 4,186
McGuire, W. P., Hoskins, W. J., Brady, M. F., Kucera, P. R., Partridge, E. E., Look, K. Y., Clarke-Pearson, D. L., & Davidson, M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601043340101 · Cited by 2,796
Self-citationIntraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Armstrong, D. K., Bundy, B., Wenzel, L., Huang, H. Q., Baergen, R., Lele, S., Copeland, L. J., Walker, J. L., & Burger, R. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052985 · Cited by 2,625
Self-citationOzols, R. F., Bundy, B. N., Greer, B. E., Fowler, J. M., Clarke-Pearson, D., Burger, R. A., Mannel, R. S., DeGeest, K., Hartenbach, E. M., & Baergen, R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.153 · Cited by 2,032
Self-citationMarkman, M., Bundy, B. N., Alberts, D. S., Fowler, J. M., Clark-Pearson, D. L., Carson, L. F., Wadler, S., & Sickel, J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.1001 · Cited by 1,080
Self-citationvan der Burg, M. E. L., van Lent, M., Buyse, M., Kobierska, A., Colombo, N., Favalli, G., Lacave, A. J., Nardi, M., Renard, J., & Pecorelli, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321002 · Cited by 705
Hoskins, W. J., McGuire, W. P., Brady, M. F., Homesley, H. D., Creasman, W. T., Berman, M., Ball, H., & Berek, J. S. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(94)70090-7 · Cited by 659
Self-citationVergote, I., De Brabanter, J., Fyles, A., Bertelsen, K., Einhorn, N., Sevelda, P., Gore, M. E., Kærn, J., Verrelst, H., Sjövall, K., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03590-x · Cited by 623
Muggia, F. M., Braly, P. S., Brady, M. F., Sutton, G., Niemann, T. H., Lentz, S. L., Alvarez, R. D., Kucera, P. R., & Small, J. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.1.106 · Cited by 601
Self-citationvan der Burg, M. E. L., van Lent, M., Buyse, M., Kobierska, A., Colombo, N., Favalli, G., Lacave, A. J., Nardi, M., Renard, J., & Pecorelli, S. (1995) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199507000-00012 · Cited by 578
(1995) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(95)90219-8 · Cited by 553
Hoskins, W. J., Bundy, B. N., Thigpen, J. T., & Omura, G. A. (1992) · Gynecologic Oncology · doi:10.1016/0090-8258(92)90100-w · Cited by 544
Zorn, K. K., Bonome, T., Gangi, L., Chandramouli, G. V. R., Awtrey, C. S., Gardner, G. J., Barrett, J. C., Boyd, J., & Birrer, M. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0508 · Cited by 376
Mucinous Epithelial Ovarian Cancer: A Separate Entity Requiring Specific Treatment
Hess, V., A'Hern, R., Nasiri, N., King, D. M., Blake, P. R., Barton, D. P. J., Shepherd, J. H., Ind, T., Bridges, J., Harrington, K., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.078 · Cited by 333
Survival Impact of Surgical Cytoreduction in Stage IV Epithelial Ovarian Cancer
井上, 隆., Montz, F. J., Lagasse, L. D., Leuchter, R. S., & Karlan, B. Y. (1999) · Gynecologic Oncology · doi:10.1006/gyno.1998.5145 · Cited by 308
Identification of Prognostic Factors in Advanced Epithelial Ovarian Carcinoma
Chi, D. S., Liao, J. B., Leon, L. F., Venkatraman, E. S., Hensley, M. L., Bhaskaran, D., & Hoskins, W. J. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2001.6328 · Cited by 243
Nishizuka, S., Chen, S.-T., Gwadry, F. G., Alexander, J., Major, S. M., Scherf, U., Reinhold, W. C., Waltham, M. C., Charboneau, L., Young, L., et al. (2003) · PubMed · Cited by 202
Age as a prognostic factor in ovarian carcinoma: The gynecologic oncology group experience
Thigpen, T., Brady, M. F., Omura, G. A., Creasman, W. T., Mcguire, W. P., Hoskins, W. J., & Williams, S. (2010) · Cancer · doi:10.1002/cncr.2820710218 · Cited by 197
Self-citationA prognostic model for ovarian cancer
Clark, T. G., Stewart, M., Altman, D. G., Gabra, H., & Smyth, J. F. (2001) · British Journal of Cancer · doi:10.1038/sj.bjc.6692030 · Cited by 192
Ovarian cancer: Survival and treatment differences by age
Ries, L. A. G. (2010) · Cancer · doi:10.1002/cncr.2820710206 · Cited by 165
McGuire, W. P., Hoskins, W. J., Brady, M. F., Kucera, P. R., Partridge, E., Look, K. Y., Clarke‐Pearson, D. L., & Davidson, M. (1996) · PubMed · Cited by 150
Self-citationPrognostic Factors of Stage IV Epithelial Ovarian Cancer: A Multicenter Retrospective Study
Akahira, J., Yoshikawa, H., Shimizu, Y., et al. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2001.6172 · Cited by 132
Epithelial ovarian carcinoma in the reproductive age group
Duska, L., Chang, Y., Flynn, C. E., Chen, A. H., Goodman, A., Fuller, A. F., & Nikrui, N. (1999) · Cancer · Cited by 121
Chan, J. K. (2003) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(03)00399-5 · Cited by 83
Aggressive chemosurgical debulking in patients with advanced ovarian cancer
Ng, L. W., Rubin, S. C., Hoskins, W. J., et al. (1990) · Gynecologic Oncology · doi:10.1016/0090-8258(90)90073-t · Cited by 36
Lund, B., Williamson, P., van Houwelingen, H. C., et al. (1990) · PubMed · Cited by 33
Cited by
Ovarian Cancer Development and Metastasis
Lengyel, E. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100105 · Cited by 1,672
du Bois, A., Reuss, A., Pujade‐Lauraine, E., Harter, P., Ray‐Coquard, I., & Pfisterer, J. (2009) · Cancer · doi:10.1002/cncr.24149 · Cited by 1,638
Kehoe, S., Hook, J., Nankivell, M., Jayson, G. C., Kitchener, H., Lopes, T., Luesley, D., Perren, T., Bannoo, S., Mascarenhas, M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62223-6 · Cited by 1,414
Alsop, K., Fereday, S., Meldrum, C., deFazio, A., Emmanuel, C., George, J., Dobrovic, A., Birrer, M. J., Webb, P. M., Stewart, C., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.8545 · Cited by 1,180
Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer
Konstantinopoulos, P. A., Ceccaldi, R., Shapiro, G. I., & D'Andrea, A. D. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0714 · Cited by 945
Metadata
- Authors
- Winter, W. E., Maxwell, G. L., Tian, C., Carlson, J. W., Ozols, R. F., Rose, P. G., Markman, M., Armstrong, D. K., Muggia, F., & McGuire, W. P.
- Venue
- Journal of Clinical Oncology
- Published
- 2007-08-20
- Volume
- 25
- Issue
- 24
- Pages
- 3621-3627
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2147539392
- Cited by
- 845
- References
- 27
- FWCI
- 42.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.